See also this year's filing and all EDGAR filings for this company.
PDF Report 0001840574_2023_Verve_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001840574, Verve Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 563,159,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 18,778,000 |
| 3 | remainder_Assets | 97,286,000 |
| 4 | LiabilitiesCurrent | 35,095,000 |
| 5 | LiabilitiesNoncurrent | 70,297,000 |
| 6 | remainder_Liabilities | 22,899,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,533,000 |
| 9 | ResearchAndDevelopmentExpense | 130,095,000 |
| 10 | remainder_Expenses | 53,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 10,294,000 |
| 13 | remainder_ComprehensiveNetIncome | -466,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 679,223,000 |
| 1 | Liabilities | 128,291,000 |
| 2 | Expenses | 167,681,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 550,932,000 |
| 5 | NetIncome | -157,387,000 |
| 6 | ComprehensiveNetIncome | -157,620,000 |
| 7 | BaseVar | 492,977,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.58 |
| 9 | EconomicCapitalRatio | 3.41 |
Edgar->Model Mapping
Feature Distribution
